Clinical NGS kit for Hematological Malignancies & analysis SW

HEMEaccuTest™ is intended for molecular genetic test of multiple genes related hematologic malignancy.

Diagnosis through qualitative analysis of hematologic malignancy

Purpose to assist in appropriate classification and prediction of prognosis

Working Process

Specification

HEMEaccuTest™
DNA RNA
Certification CE-IVD RUO
Target disease Acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic/myeloproliferative neoplasm, multiple myeloma, lymphoma
Target Enrichment method Hybridization & capture method
Quantity 96 test/kit (8 runs per kit, up to 12 samples per run)
Specimen Blood, bone marrow and lymph nodes
Target gene 108 genes 53 genes
(5 house-keeping genes)
Target size 305 kb 129 kb
Probes 5′-biotinylated oligos (DNA based)
Hands on time 3 days 3.5 days
Variants type SNV, In, Del Fusion
NGS platform & reagent kit illumina MiSeq, MiSeq Dx / MiSeq Reagent kit, v3, 300cycles
Analysis solution NGeneAnalySys™ (CE)

Ordering information

Products Cat.no Quantity
RUO CE-IVD
HEMEaccuTest™ DNA
& NGeneAnalySys

NGB121R-096

NGB121V-096

96 tests

NGB121R-048

NGB121V-048

48 tests

HEMEaccuTest™ RNA
& NGeneAnalySys

NGB112R-012

On the Process

12 tests

NGB122R-048

48 tests